The primary drawback with biologic therapy is the necessity for life-long or long-term treatment, the failure of which can lead to incomplete resolution or recurrences. Combination with other agents such as methotrexate can enhance the efficacy and response.

Live vaccines and contact with infectious agents should be avoided during infliximab therapy due to the markedly depressed immunity that can result in disseminated infections.